SCHEMBL2642447

SCHEMBL2642447

[NH]Cc1ccc(C(N)=O)nc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.49
VNN1 O95497 4/20 0.48
P4HTM Q9NXG6 3/20 0.46
NAMPT P43490 1/20 0.42
SIRT6 Q8N6T7 2/20 0.41
TSHR P16473 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
ALOX15 P16050 1/20 0.41
NFKB1 P19838 1/20 0.41
THPO P40225 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2642450 0.82 KMT2A (0.50) KMT2AVNN1P4HTMNAMPTSIRT6
SCHEMBL29716008 0.82 KMT2A (0.50) KMT2AVNN1P4HTMNAMPTSIRT6
SCHEMBL2645722 0.82 KMT2A (0.50) KMT2AVNN1P4HTMNAMPTSIRT6
Hydrochloric Acid SCHEMBL6482968 0.81 KMT2A (0.49) KMT2AVNN1P4HTMNAMPTSIRT6
SCHEMBL5755133 0.81 L3MBTL1 (0.49) KMT2AVNN1P4HTMNAMPTSIRT6
SCHEMBL2642695 0.81 P4HTM (0.46) KMT2AP4HTMTSHRKDM4EMEN1
Hydrochloric Acid SCHEMBL6485768 0.81 KMT2A (0.49) KMT2AVNN1P4HTMNAMPTSIRT6
SCHEMBL30365828 0.81 KMT2A (0.49) KMT2AVNN1P4HTMNAMPTSIRT6
SCHEMBL6138523 0.78 MAPT (0.46) KMT2AP4HTMTSHRKDM4EMEN1
SCHEMBL28252056 0.78 P4HTM (0.49) KMT2AVNN1P4HTMNAMPTSIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765789-B2 2-pyridinecarboxamide derivatives MSD K.K. (JP) 2014-07-01 US disclosed
US-20130085156-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES MSD K.K. (JP) 2013-04-04 US disclosed
US-8344003-B2 2-pyridinecarboxamide derivatives MSD K. K. (JP) 2013-01-01 US disclosed
US-20100041660-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES MSD K.K. (JP) 2010-02-18 US disclosed
US-7629362-B2 2-pyridine carboxamide derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2009-12-08 US disclosed
US-20060258701-A1 Novel 2-pyridinecarboxamide derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-11-16 US disclosed
EP-1598349-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-11-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130085156-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES GCKR, GCK, HK2 KMT2A 1297/4885VNN1 4206/4885P4HTM 2758/4885
US-20060258701-A1 Novel 2-pyridinecarboxamide derivatives GCKR, GCK, HK2 KMT2A 1311/4885VNN1 4245/4885P4HTM 2891/4885
US-20100041660-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES GCKR, GCK, HK2 KMT2A 1297/4885VNN1 4206/4885P4HTM 2758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.